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Atopic dermatitis (AD) is a chronic inflammatory skin condition that 
typically presents within the first 2 years of life.[1] The global prevalence 
in 6 - 7-year-old children ranges from 0.9% to 22.5%.[2] Remissions 
and relapses occur, with 25% of cases persisting into adulthood.[3] 
AD is associated with reduced quality of life.[4] Intractable pruritus 
and sleep disturbance are characteristic symptoms and have been 
associated with psychological distress, behavioural problems and 
reduced school performance.[5] Children with AD are at increased 
risk of developing allergic rhinitis and asthma.[3] AD has also been 
associated with an increase in non-allergic comorbid conditions 
including infections, psychiatric disorders (depression, anxiety, 
attention-deficit/hyperactivity disorder), obesity and cardiovascular 
disorders, among others, contributing to the high public health 
burden of the disease.[6]
Both skin barrier defects (the ‘outside-in’ hypothesis) and 
immunological alterations (the ‘inside-out’ hypothesis) contribute 
to the pathogenesis of AD.[7] A disrupted microbiota with reduced 
diversity and increased Staphylococcus aureus colonisation is also 
hypothesised to play a role.[8] Zinc is an essential trace element, 
and low zinc levels may contribute to the pathogenesis of AD by all 
three of these mechanisms. First, low zinc levels may compromise 
epidermal barrier function. Zinc is required for proliferation and 
migration of keratinocytes in wound healing via ZnR/GPR-39, a 
keratinocyte G-protein-coupled receptor that responds to changes 
in extracellular zinc concentrations.[9] Furthermore, a zinc finger 
transcription factor is required for OVOL-1 expression of filaggrin, 
an epidermal barrier protein implicated in the pathogenesis of AD.[10] 
The zinc transporter, ZIP10, is also involved in regulation of genes 
required for epidermal homeostasis and barrier function.[11] Second, 
low zinc levels may promote cutaneous inflammation. An AD-like 
eruption can be induced in DS-Nh mice by a zinc-deficient diet. 
This eruption is associated with altered immune profiles, including 
increased production of the atopy-associated proinflammatory Th-2 
cytokines.[12] Conversely, application of topical zinc oxide to damaged 
skin has anti-inflammatory effects.[13] Third, low zinc levels may 
promote S. aureus colonisation. Although the relationship between 
total body zinc and cutaneous S. aureus activity is not known, 
zinc oxide nanoparticles have in vitro activity against S. aureus.[14] 
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Background. Atopic dermatitis (AD) is a common chronic inflammatory skin condition that disproportionately affects children and is 
associated with reduced quality of life. Zinc deficiency may contribute to the pathogenesis of AD because zinc plays a role in epidermal 
barrier integrity and the immune system. Systematic review evidence suggests that low zinc is associated with AD, but limitations of 
included studies support further investigation.
Objectives. To investigate hair zinc concentrations in children with AD v. healthy controls in a low- to middle-income country setting.
Methods. One hundred and five children aged 1 - 12 yea rs participated in a frequency-matched for age case-control study. The outcome 
variable, AD, was confirmed by a clinician and corroborated using the UK Working Party criteria. The primary predictor, long-term 
average zinc concentration, was determined by measuring hair zinc using inductively coupled mass spectrometry. Baseline demographic 
characteristics, anthropometry and measures of socioeconomic status were included in our logistic regression analysis. Subgroup analysis 
was performed where interaction terms suggested effect modification.
Results. Using data from the overall sample, population median hair zinc was not significantly different between children with AD and 
healthy controls. However, subgroup analysis suggested a clinically and statistically significant difference in median zinc between children 
with AD (175.35 µg/g) and healthy controls (206.4 µg/g) in the older age group (5 - 12 years) (p=0.01). In this age group, multivariable 
logistic regression analysis also found significantly decreased hair zinc concentrations in AD (odds ratio 0.83; 95% confidence interval 
0.66 - 0.96; p=0.046).
Conclusions. The inverse association between zinc status and AD in children aged 5 - 12 years in our setting is consistent with the 
international literature. The clinical importance of decreased zinc levels in AD is not yet known. Further investigation into relevant 
underlying mechanisms seems warranted given the global reach of AD, its effect on quality of life, and the low cost of potential zinc-based 
interventions.
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Furthermore, in the abovementioned DS-Nh mouse model of AD, zinc 
deficiency was also associated with increased S. aureus colonisation.[12]
A systematic review and meta-analysis of observational studies 
suggests that low zinc (as measured in serum, erythrocytes and hair) 
is associated with AD.[15] However, owing to limitations of included 
studies, further investigation is needed. Furthermore, previous 
studies are primarily from upper middle-income countries (UMICs) 
and high-income countries (HICs), and results are not necessarily 
generalisable to low- to middle-income country (LMIC) settings. The 
zinc-AD relationship has not been studied previously in the South 
African (SA) context, where the prevalence of AD is increasing and 
zinc deficiency remains a concern, despite mandatory fortification of 
maize and wheat flour.[16,17]
Objectives
To perform a case-control study to investigate hair zinc concentra-
tions in children with AD v. healthy controls.
Methods
Case selection
Sequential children presenting with AD to a specialised outpatient 
dermatology service at Red Cross War Memorial Children’s Hospital 
(RCWMCH), Cape Town, SA, were approached for potential inclusion 
into the study. Predefined inclusion criteria included age 1 - 12 years 
and corroboration of the clinical diagnosis of AD using the UK 
Working Party criteria.[1] Exclusion criteria were acute illness, non-
allergic comorbid chronic disease, infected AD, inadequate scalp hair 
for sampling, and use of multivitamins or zinc supplements within the 
past 3 months. The study was approved by the University of Cape Town 
Human Research Ethics Committee (ref. no. HREC 473/2017), and 
informed consent was obtained from primary caregivers.
Control selection
Healthy controls were frequency-matched for age only. Adults 
accompanying children aged <5 years (excluding those aged <1 year) 
were approached in clinic waiting rooms during the school holidays. 
These children were mainly friends or family of patients attending 
various medical, surgical and dental outpatient clinics at RCWMCH. 
In addition to the abovementioned exclusion criteria, controls had no 
history of atopic or allergic disease and were not first-degree relatives 
of cases.
Because there were few healthy controls aged ≥5 years in clinic 
waiting rooms, controls aged 5 - 12 years were recruited from a local 
school. Class teachers were informed of the eligibility criteria and 
were asked to choose the required number of children by drawing 
names of eligible children from a hat. The research team visited 
the school on a subsequent day to collect data from children whose 
parents had provided informed consent.
Baseline demographic characteristics
Data were collected on age, sex and frequency of hair washing. All 
participants were weighed and measured. Weight and length/height 
measurements were converted to age-appropriate World Health 
Organization (WHO) z-scores: weight for length (age 1 - 2 years), 
weight for height (2 - 5 years) and body mass index (BMI) for age 
(≥5 years).
Clinical characteristics
The SCORing for Atopic Dermatitis (SCORAD) instrument was 
completed for all cases by the same clinician (NAG).[18] The Children’s 
Dermatology Life Quality Index (CDLQI) was used for all children 
aged >5 years.[19] The question on swimming in the CDLQI was 
omitted, as few children had regular access to swimming pools. Use 
of medication was documented, and it was confirmed that children 
had not taken any zinc-containing supplements during the preceding 
3 months.
Socioeconomic status
A socioeconomic status questionnaire for caregivers was designed 
based on the National Income Dynamics Survey.[20] This survey 
was chosen because of its appropriateness for the SA context 
and local validation. Three variables were derived from these 
data: primary caregiver school years completed, household income 
indicator (midpoint of the participant’s household income bracket), 
and number of people in the household.
Hair zinc analysis
Zinc status was assessed using hair zinc measurements. This method 
was selected because it is less invasive than measuring serum or 
erythrocyte zinc. Furthermore, hair grows at an average of 1 cm per 
month, and analysis of proximal hair segments may therefore give an 
indication of average zinc levels over a longer period (e.g. 3 months 
for 3 cm hair), rather than zinc levels at a random single point in time. 
Hair zinc may be a better marker of marginal zinc deficiency than 
serum zinc, perhaps because the slow uptake of zinc by the hair is 
preferentially reduced in states of decreased zinc availability.[21]
Hair was collected from the posterior vertex and cut as close 
to the scalp as possible using a standard protocol. Samples were 
stored in paper envelopes at room temperature before processing 
at the University of Cape Town Hair and Skin Laboratory. Only 
the proximal 3 cm of hair was used, and hair was cut using ceramic 
scissors. Ten milligram aliquots of hair were placed in a Pyrex 
beaker and washed for 10 minutes in each of the following, in 
order: acetone, methanol and deionised water. The samples were 
air-dried overnight. Ten millilitres of 65% Suprapur Nitric Acid 
(Sigma-Aldrich, Germany) was added to each sample in Teflon. 
Samples then underwent microwave digestion using a MARS 6 
instrument (CEM Corp., USA) for 30 minutes at 200°C.[22] After 
cooling, digested samples were filtered using 0.45 µm syringe filters 
and stored in a fridge (–4 - –6°C). All samples (including 10 blanks, 
prepared using the same protocol but omitting the hair) were 
then transported to the Stellenbosch University Central Analytical 
Facilities, where they underwent a 7-times dilution prior to analysis 
on an Agilent 7900 ICP-MS quadrupole mass spectrometry system 
(Agilent, USA).
Statistical analysis
As the distribution of hair zinc concentrations was skewed to the right, 
differences between groups were analysed using non-parametric 
Mann-Whitney U-tests. Effect sizes for the Mann-Whitney U-test 
were calculated using the r statistic (0<r<1).[23] Univariate and 
multivariable logistic regression models were fitted, with odds of 
AD as the outcome variable. The interaction of age and zinc was a 
significant predictor of AD, suggesting effect modification. Subgroup 
analysis according to age group (≥1 - <5 years and 5 - 12 years) was 
therefore performed. Variables with p<0.1 in the univariate subgroup 
analyses were identified as potential confounders and were therefore 
adjusted for in the multivariable models. Results are reported as 
odds ratios (ORs) with 95% confidence intervals (CIs), and p<0.05 
was used as the cut-off for statistical significance. The final models 
were also repeated using multiple imputation for participants with 
missing socioeconomic status variables (≤10%) to confirm consistent 
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results. Analyses were performed using R version 3.6.0 (R Core Team, 
Austria), using the following packages: base, stats, rcompanion, mice, 
graphics and ggplot2.
Results
Baseline demographic characteristics
One hundred and five children (AD and controls) participated in 
our case-control study investigating the association between zinc 
status and AD. Participant characteristics are presented in Table 1. 
Of the children, 51% were aged ≥1 - <5 years and 49% 5 - 12 years. 
Fifty-nine percent were female. Ninety-four percent of children 
aged ≥1 - <5 years and 96% of children aged 5 - 12 years had WHO 
anthropometry scores within two standard deviations (SDs) of the 
mean. No child was found to be underweight. Fifty-seven percent of 
children washed their hair less than three times a week, with similar 
findings between cases and controls (57% and 56%, respectively).
Clinical characteristics
According to the SCORAD instrument, 90% of participants had 
moderate or severe AD, with only 10% falling in the mild category. 
Similarly, the median (interquartile range (IQR)) CDLQI score was 
17.5 (15 - 21.8), with the maximum possible adverse quality of life 
represented by a score of 27.
Socioeconomic status
The median household income indicator in the overall sample 
was ZAR4 500 (~USD318 or EUR283 at the time of writing) per 
month.[24] The median household income indicator was significantly 
higher in controls (ZAR8 500) compared with cases (ZAR4 500). 
The median (IQR) number of people permanently residing in the 
household was 5 (4 - 6), and the median number of caregiver school 
years completed was 12. As shown in Table 1, in contrast to the 
median household income indicator, the latter two socioeconomic 
variables did not differ greatly between cases and controls.
Comparison of hair zinc between participants  
with AD and controls
The distribution of hair zinc concentrations was skewed to the right 
(Fig. 1). For the overall sample, the median zinc concentration was 
176.78 µg/g. Twenty-one of the 105 participants (20%) had a hair zinc 
concentration <130 µg/g, and none had a concentration <70 µg/g.
As shown in Table 2, there was no significant difference in median 
zinc concentration in participants with AD v. controls (164.86 v. 
189.62 µg/g; p=0.1). When participants were stratified by age, there 
was similarly no significant difference in median zinc concentration 
between participants with AD v. controls in the younger children aged 
≥1 - <5 years (142.94 v. 152.44 µg/g; p=0.53). However, there was a 
statistically significant lower median zinc concentration in participants 
with AD v. controls in the older children aged 5 - 12 years (175.35 v. 
206.4 µg/g; p=0.01). There was a small effect size for the overall sample 
(r=0.16) and the younger children (r=0.09), with a medium effect size 
for the older children (r=0.35). A visual representation of these data is 
provided using box-and-whisker plots in Figs 2 and 3.
Association between hair zinc concentration and  
odds of AD
In the overall sample, univariate analysis did not show a significant 
association between hair zinc concentration and AD (OR 0.96; 
Table 1. Participant characteristics stratified by AD status
Characteristic Total (N=105) AD (N=40) No AD (N=65)
Age (years), n (%)
≥1 - <5 54 (51.4) 20 (50.0) 34 (52.3)
5 – 12 51 (48.6) 20 (50.0) 31 (47.7)
Female sex, n (%) 59 (56.2) 21 (52.5) 38 (58.5)
WHO weight for length/height (<5 years), n (%)
Within 2 SD of mean 51/54 (94.4) 18/20 (90.0) 33/34 (97.1)
>2 SD of mean 3/54 (5.6) 2/20 (10.0) 1/34 (2.9)
<2 SD of mean 0 0 0
WHO BMI for age (5 - 12 years), n (%)
Within 2 SD of mean 49/51 (96.1) 20/20 (100) 29/31 (93.5)
>2 SD of mean 2/51 (3.9) 0 2/31 (6.5)
<2 SD of mean 0 0 0
Hair wash frequency (times per week), n (%)
<3 59/104 (56.7) 23/40 (57.5) 36/64 (56.3)
≥3 45/104 (43.3) 17/40 (42.5) 28/64 (43.8)
SCORAD category, n (%)
Mild - 4/40 (10.0) -
Moderate - 10/40 (25.0) -
Severe - 26/40 (65.0) -
CDLQI
Median (IQR) - 17.5 (15 - 21.8) -
Mean (SD) - 18.3 (5.3) -
Household income indicator (ZAR), median (IQR) 4 500 (2 250 - 8 500) 4 500 (2 250 - 8 500) 8 500 (2 812 - 19 000)
People permanently living in the household (n), median (IQR) 5 (4 - 6) 4 (4 - 5) 5 (4 - 6)
School years completed, median (IQR) 12 (11 - 12) 12 (11 - 12) 12 (11 - 12)
AD = atopic dermatitis; WHO = World Health Organization; SD = standard deviation; BMI = body mass index; SCORAD = SCORing for Atopic Dermatitis instrument;  
CDLQI = Children’s Dermatology Life Quality Index; IQR = interquartile range.
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95% CI  0.90 - 1.00; p=0.12) (Table 3). 
However, the interaction of age and 
zinc was a signifi cant predictor of AD 
(p=0.02), suggesting effect modification, 
and subgroup analysis by age category was 
therefore undertaken.
Subgroup analysis by age category 
(Table 4) showed that a higher hair zinc 
concentration was significantly associated 
with decreased odds of AD in older 
children (aged 5 - 12  years) (OR 0.87; 95% 
CI  0.75 - 0.97; p=0.03), but not in younger 
children (≥1 - <5  years) (OR 0.99; 95% 
CI 0.92 - 1.04; p=0.62). Anthropometric 
characteristics, caregiver education and 
household income indicator were identified 
as potential confounders (p<0.1 in subgroup 
univariate analyses). As shown in Table 5, 
multivariable analysis adjusting for these 
confounders confirmed that higher hair 
zinc concentration was still associated with 
a significantly decreased odds of AD in 
children aged 5 - 12 years (OR 0.83; 95% 
CI 0.66 - 0.96; p=0.046). Put differently, 
in children aged 5 - 12 years, for every 
10 µg/g increase in hair zinc, the odds of 
AD decreased by 17% after adjusting for 
anthropometric characteristics, caregiver 
education and household income. Repeating 
the analysis using multiple imputation for 
8 participants with missing socioeconomic 
data points yielded comparable results 
(OR  0.81; 95% CI 0.65 - 0.95; p=0.007) 
(Table 6).
Discussion
The objective of this study was to investigate 
the association between hair zinc and AD 
in children in an LMIC context. We found 
higher median hair zinc concentrations 
in cases v. controls, but this was only 
statistically significant in older children (5 - 
12 years of age). Similarly, in our logistic 
regression analysis, we found a significant 
interaction between age and zinc in 
predicting the outcome of AD. Multivariable 
analysis confirmed that increasing hair zinc 
concentrations were significantly associated 
with decreased odds of AD in children aged 
5 - 12 years, even after adjusting for potential 
confounders (OR 0.83; 95% CI 0.66 - 0.96; 
p=0.046).
Analysing proximal hair segments for 
zinc concentration gives a useful indication 
of average hair zinc levels, with 1 cm of 
scalp hair correlating to ~1 month of 
growth. Limiting analysis to the proximal 
3 cm also reduces the risk of a potential 
‘washout effect’, although this effect may 
not be a significant consideration in hair 
zinc analysis, unlike other substances.[25] 
Assessment of average zinc levels, rather 
than serum or erythrocyte zinc, is also useful 
considering that zinc is not stored in the 
body and regular dietary intake is therefore 
necessary.[26] It has also been suggested that 
hair zinc may be more sensitive in detecting 
marginal zinc deficiency.[21]
Three other published studies report 
reduced hair zinc concentrations in partici-
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Fig. 1. Distribution of hair zinc concentrations in the overall sample (N=105).
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Fig. 2. Comparison of hair zinc in children: overall sample (N=105).
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Fig. 3. Comparison of hair zinc stratified by age group: (A) children aged <5 years (n=54), (B) children 
aged 5 - 12 years (n=51).
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pants with AD v. controls. The first, a study of Italian children aged 
2 - 14 years published in 1987,[27] reported a mean (SD) hair zinc 
concentration of 99 (10) v. 147 (9) µg/g in participants with AD v. 
controls (p<0.05). The second, a study of Egyptian children aged 
2 - 10 years published in 1990,[28] reported a mean (SD) hair zinc 
concentration of 164.8 (23.6) v. 194.5 (18.6) µg/g in participants with 
AD v. controls (p<0.001). The third, a study of South Korean children 
aged 2 - 14 years published in 2014,[29] reported a mean (SD) hair zinc 
Table 2. Comparison of hair zinc (µg/g) by age and AD status
Patient group Total AD No AD p-value† Effect size (r)
Children <5 years, median (IQR) 152.44 (118.03 - 204.64) 142.94 (109.73 - 212.08) 152.44 (129.12 - 201.78) 0.53 0.09
Children 5 - 12 years, median (IQR) 190.06 (168.61 - 230.50) 175.35 (159.01 - 210.21) 206.4 (176.1 - 267.6) 0.01* 0.35‡
Overall children, median (IQR) 176.78 (138.18 - 219.71) 164.86 (123.54 - 210.21) 189.62 (150.71 - 222.12) 0.10 0.16
AD = atopic dermatitis; IQR = interquartile range.
*p<0.05.
†p-values derived by Mann-Whitney U-test.
‡0.3≤r<0.5 denotes medium effect size.
Table 3. Univariate logistic regression analysis with outcome y=p(AD) using overall sample
Variable n Estimate OR 95% CI of OR p-value
Zinc (per 10 µg/g increment) 105 –0.04 0.96 0.90 - 1.00 0.12
Age (years) 105 0.0005 1.00 0.89 - 1.12 0.99
Age category 105 0.09 1.10 0.50 - 2.42 0.82 
Male sex 105 0.24 1.27 0.57 - 2.82 0.55
Anthropometry score 105 –0.10 0.91 0.61 - 1.33 0.62
Education (caregiver school years completed) 100 –0.12 0.87 0.62 - 1.27 0.51
Household income indicator (ZAR) 94 –0.05 0.9999 0.9998 - 0.99998 0.02*
Number of household members 100 –0.12 0.88 0.70 - 1.10 0.28
Age × zinc 105 –0.003 0.997 0.99 - 0.999 0.02*
Household income indicator × zinc 94 –0.01 0.999999 0.999998 - 1.000000 0.20
AD = atopic dermatitis; OR = odds ratio; CI = confidence interval.
*p<0.05.
Table 4. Subgroup analysis: Univariate logistic regression analysis with outcome y=p(AD) stratified by age
Age ≥1 - <5 years Age 5 - 12 years
Variable n Estimate OR 95% CI of OR p-value n Estimate OR 95% CI of OR p-value
Zinc (per 10 µg/g 
increment)
54 -0.01 0.99 0.92 - 1.04 0.62 51 –0.14 0.87 0.75 - 0.97 0.03
Male sex 2 0.48 1.62 0.53 - 5.01 0.40 51 –0.01 0.99 0.32 - 3.09 0.99
Anthropometry score 54 0.50 1.65 0.95 - 3.02 0.09*| 51 –0.80 0.45 0.20 - 0.85 0.03*
Education (caregiver school 
years completed)
53 0.13 1.14 0.73 - 1.85 0.59 47 –1.60 0.74 0.03 - 0.65 0.03*
Household income 
indicator (ZAR)
50 –0.03 0.99995 0.9998 - 1.00 0.48 44 –0.03 0.9999 0.9997 - 0.99995 0.01* 
Number of household 
members
53 –0.22 0.80 0.56 - 1.08 0.18 47 –0.01 0.99 0.70 - 1.38 0.97
Income per person 
indicator (ZAR)
50 0.01 1.00 0.999 - 1.00 0.94 42 –0.0004 0.9996 0.999 - 0.9999 0.04*
AD = atopic dermatitis; OR = odds ratio; CI = confidence interval.
*p<0.1.
Table 5. Subgroup analysis: Multivariate logistic regression analysis with outcome y=p(AD) stratified by age group
Age ≥1 - <5 years (n=50) Age 5 - 12 years (n=43)
Variable Estimate OR 95% CI of OR p-value Estimate OR 95% CI of OR p-value
Zinc (per 10 µg/g increment) –0.04 0.96 0.89 - 1.02 0.28 –0.19 0.83 0.66 - 0.96 0.046*
Anthropometry score 0.52 1.68 0.90 - 3.36 0.12 –0.81 0.44 0.15 - 1.04 0.09
Education (caregiver school years 
completed)
0.08 1.09 0.67 - 1.85 0.75 –1.01 0.37 0.03 - 1.28 0.22 
Household income indicator (ZAR) –0.00008 0.9999 0.9997 - 1.00 0.33 –0.0002 0.9998 0.9997 - 0.99996 0.03*
AD = atopic dermatitis; OR = odds ratio; CI = confidence interval.
*p<0.05.
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concentration of 113.10 (33.36) v. 130.9 (36.63) µg/g in participants 
with AD v. controls (p=0.012). Interestingly, in all these studies, 
average zinc levels were significantly lower in children with AD 
across the age spectrum, even though all included children aged <5 
years. Subgroup analysis by age was not indicated or performed. The 
lack of a statistically significant difference in hair zinc in the younger 
children (≥1 - <5 years) in our study is therefore new.
Publication bias is one potential reason why the null association 
in younger children has not been reported previously, but there are 
several other possibilities. First, zinc deficiency may be more relevant 
to older children because of a different AD molecular phenotype. This 
hypothesis is based on findings of differing age-related molecular 
phenotypes in adult AD, but relevance to persons aged <18 years 
and relevance to zinc metabolism are not yet known.[30] Second, our 
findings may reflect failure to reject a false null hypothesis (type 
II statistical error). Third, the difference in zinc levels between 
children with AD and healthy children may be attenuated by the 
effects of the mandatory food fortification programme in SA. Dietary 
practices may also vary by age, with older children consuming lower 
proportions of zinc-rich or zinc-fortified foods relative to their age-
appropriate dietary requirements. Fourth, children aged <5 years 
attending RCWMCH benefit from good uptake of routine growth 
monitoring and nutritional health promotion via the Road to Health 
booklet, thus mitigating the risk of relative zinc deficiency in this 
group. This protective effect may not extend to older children, as the 
focus of the Road to Health booklet is the first 5 years of life.[31]
Several other studies have used erythrocyte or serum zinc measures 
to compare participants with AD with controls. Meta-analysis 
confirmed overall reduced zinc across eight studies analysing serum 
zinc in AD v. controls (standardised mean difference 0.66; 95% 
CI 0.21 - 1.10; p=0.004).[15] Similarly, two studies of erythrocyte 
zinc showed lower concentrations in participants with AD v. 
controls. [32,33] Of note, most of the studies originated from UMIC 
or HIC settings. [15] An exception is a study from Bangladesh,[34] 
reporting a mean (SD) serum zinc concentration of 0.30 (0.02) 
mg/L in participants with AD v. 0.02 (0.06) mg/L in healthy controls 
(p<0.001). Participant age ranged from 15 to 35 years, therefore 
representing an older age group than that in our study.
The clinical significance of the association between low zinc 
levels and AD has yet to be elucidated. Some authors have 
suggested hair zinc concentrations <70 or <130 µg/g as cut-offs 
for zinc deficiency. [21,35] No children in our sample had a hair zinc 
concentration <70 µg/g, and 20% of our sample had concentrations 
<130 µg/g. However, as there are no locally or internationally 
validated reference ranges for hair zinc concentrations, these 
findings should be interpreted with caution. Furthermore, the 
level of zinc deficiency required to contribute clinically to AD 
symptoms is not known and may differ from normal reference 
ranges. Clinically significant zinc thresholds may also differ by age, 
in line with evidence suggesting that normal total body zinc levels 
increase with age during childhood.[21,36] Our data are therefore 
useful in confirming a statistically significant difference in hair zinc 
in children aged 5 - 12 years in an LMIC setting, but further study is 
required to prove clinical significance. One such approach would be 
randomised controlled trials of zinc supplementation in AD. Two 
such studies have previously been undertaken, but methodological 
limitations, different outcome measures and conflicting results 
make interpretation difficult.[15]
Study limitations
Some of the strengths and limitations of our study have already been 
mentioned. Further limitations include the risk of selection bias, 
particularly regarding different selection of controls for participants in 
different age categories, and the relatively small sample size (N=105). 
Because we did not measure zinc levels prior to establishing the 
outcome, we cannot be sure that reverse causality is not the explanation 
for our findings. However, as we indicated earlier, there is other 
evidence to support the hypothesis that low zinc levels may be causally 
related to expression of AD. Furthermore, our conclusions are drawn 
from a subgroup analysis. We do not know whether we would have 
found the same association in younger children if we had sourced 
younger controls from the general population, instead of in hospital 
waiting room areas.
Despite the above limitations, our study has several strengths. 
First, the outcome of interest, AD, was confirmed by a clinician and 
corroborated using independent criteria. Second, a detailed description 
of controls is provided, which was missing from earlier publications. 
Third, few have investigated the zinc-AD relationship in LMIC settings, 
and to our knowledge none have done so in sub-Saharan Africa.
Conclusions
Consistent with the international literature, our study showed an 
inverse association between zinc status and AD in older children 
(aged 5 - 12 years). While the role of total body zinc concentrations 
in the complex aetiopathogenesis of AD is likely to be small, it needs 
to be considered in the context of the global reach of AD, its profound 
effect on childhood morbidity, and the low cost of potential zinc 
supplementation. Further research into the underlying mechanisms 
of lower zinc levels in AD, and whether these inform treatment 
targets, is therefore warranted.
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Table 6. Subgroup analysis: Multivariate logistic regression analysis with outcome y=p(AD) stratified by age group and using 
multiple imputation
Age ≥1 - <5 years (n=54) Age 5 - 12 years (n=51)
Variable Estimate OR 95% CI of OR p-value Estimate OR 95% CI of OR p-value
Zinc (per 10 µg/g increment) –0.03 0.97 0.91 - 1.03 0.28 –0.21 0.81 0.65 - 0.95 0.007**
Anthropometry score 0.59 1.81 1.00 - 3.52 0.06 –0.92 0.40 0.14 - 0.92 0.05
Education (caregiver school 
years completed)
0.09 1.10 0.68 - 1.85 0.71 –1.12 0.33 0.02 - 1.19 0.21
Household income indicator 
(ZAR)
–0.0001 0.9999 0.9997 - 1.00 0.23 –0.0001 0.9999 0.9997 - 0.99997 0.04*
AD = atopic dermatitis; OR = odds ratio; CI = confidence interval.
*p<0.05; **p<0.01.
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